Dr Jack Cush reviews the news, journal reports and FDA approvals
Perspectives on the safety of a JAK inhibitor in RA, PsA, and AS – Featuring Drs Wickersham, Winthrop, and Ritchlin Sponsored by AbbVie Medical Affairs
Drs. Pendleton Wickersham (Arthritis Associates PA, San Antonio, TX), Kevin Winthrop (OHSU, Portland, OR), and Christopher Ritchlin (URMC, Rochester, NY) come together to share their experiences discussing with patients the benefit-risk of a JAK inhibitor.
Great and Not-So Great (9.30.2022)
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.
Heavy Metal Rheumatology (9.23.2022)
Thanks to all of you for your kind comments and great reviews of our weekly podcast. Please let us know how we can improve by emailing me (email@example.com) or recording your suggestion using the "Ask Cush Anything" link on our email and website.
CD19 CAR T Cell Therapy in SLE (9.16.2022)
Dr. Jack Cush reviews the news, journal reports, ACR and FDA announcements from the past week on RheumNow.com
Does Fibromyalgia Need B12
Can we predict the bad outcomes? Like when ITP evolves into SLE; or when psoriasis will develop arthritis; or if Sjogens will develop lymphoma? Dr. Jack Cush reviews these journal reports and this past weeks news from RheumNow.com
StillsNow Podcast August 2022 - Genetic Testing for Autoinflammatory Diseases
Featuring a discussion with Dr. Susan Shenoi from Seattle Childrens Hospital
Great podcast to stay updated with the latest knowledge in rheumatology. Dr. Cush and his behind the scene helpers put in a huge amount of effort to condense the latest and the most important content for this podcast. His presentation style is unbeatable. Really thankful to have this podcast available. The content is most suitable for Rheumatologists because of its specialized information.
Best rheumatology podcast out there.
Dr. Cush and The Rheumnow podcast deliver best 15 minutes of education I get all week. A must listen for rheumatologists. Thanks for all the clinical pearls.